Italy solves its biotech chicken-and-egg problem

Once a no-go zone for investors, Italy has been growing an ecosystem of new funds and infrastructure to support company creation, promising more success stories that could in turn attract more investors and inspire more entrepreneurs.

After years of virtually no venture capital available for Italian start-ups, a handful of dedicated life sciences funds have started tapping the region’s rich science, focusing on early-stage investments, where most of the young biotech sector’s opportunities lie. ...